Vlad Skutelnik

Macroaxis Contributor

Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management.
Company Analysis
editors@macroaxis.com

Vlad Skutelnik Latest Stories - Published

BNS
  6 hours ago at Macroaxis 
By Vlad Skutelnik
Bank of Nova Scotia is scheduled to announce its earnings tomorrow. The upcoming quarterly report is expected on the 30th of November 2021. Because some of us are getting excited about financial services space, it makes sense to sum up Bank Of Nova in greater detail. We will discuss the reasons why it is still possible for the company to generate above-average margins given the latest economic outlook.
BNED
  few hours ago at Macroaxis 
By Vlad Skutelnik
The current year Interest Coverage is expected to grow to 2.92. The current year Calculated Tax Rate is expected to grow to 94.14. Barnes Noble Education is scheduled to announce its earnings tomorrow. The upcoming quarterly report is expected on the 30th of November 2021. As some conservatives are trying to avoid consumer cyclical space, we'll digest Barnes Noble Education a little further and explain its current market possibilities. We will evaluate if Barnes Noble shares are reasonably priced going into December. Barnes Noble Education probability of distress is under 39 percent. Will Barnes Noble shareholders continue to acquire in December?
INFA
  just now at Macroaxis 
By Vlad Skutelnik
Whilst many millenniums are getting more into business services space, it makes sense to go over Informatica Inc Cl. What exactly are Informatica Inc shareholders getting in December? Is current the firm value sustainable? We will go over Informatica Inc valuation drivers to give you a better outlook on taking a position in it.
CARS
  19 hours ago at Macroaxis 
By Vlad Skutelnik
Cars Long Term Debt to Equity is relatively stable at the moment as compared to the past year. Cars reported last year Long Term Debt to Equity of 1.69. As of 11/28/2021, Calculated Tax Rate is likely to grow to 30.91, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (805.9 M). While some of us are becoming more passionate about consumer cyclical space, it makes sense to sum up Cars Inc in greater detail. We will check if it is still possible for Cars to minimize net losses this year. In this post, I will also go over a few different drivers affecting Cars' products and services, and explain how it may impact Cars retail investors.
MRNA
  14 hours ago at Macroaxis 
By Vlad Skutelnik
While many traders are getting carried away by overanalyzing competition within healthcare space, it is quite reasonable to go over both, Moderna and Brickell Biotech as potential short-term investments. We are going to analyze some of the competitive aspects of both Moderna and Brickell.
ATNF
  20 hours ago at Macroaxis 
By Vlad Skutelnik
180 Life Enterprise Value is projected to decrease significantly based on the last few years of reporting. The past year's Enterprise Value was at 51.17 Million. The current year Invested Capital Average is expected to grow to about 6.2 M, whereas Earnings before Tax are forecasted to decline to (11.8 M). While many traders are getting carried away by overanalyzing healthcare space, it is reasonable to digest 180 Life Sciences. We will evaluate if 180 Life shares are reasonably priced going into December. Here I will also expose some primary fundamental factors affecting 180 Life's services, and outline how it will impact the outlook for investors this year.
APT
  22 hours ago at Macroaxis 
By Vlad Skutelnik
The next fiscal quarter end is expected on the 31st of December 2021. The stock is currently undergoing an active upward rally. Alpha Pro Earnings per Diluted Share are comparatively stable at the moment as compared to the past year. Alpha Pro reported Earnings per Diluted Share of 1.94 in 2020. Enterprise Value over EBIT is likely to gain to 4.11 in 2021, whereas Invested Capital is likely to drop slightly above 39.9 M in 2021. As many millenniums are trying to avoid industrials space, it makes sense to review Alpha Pro Tech a little further and try to understand its current market patterns.
ARCE
  a day ago at Macroaxis 
By Vlad Skutelnik
Arco Platform is scheduled to announce its earnings tomorrow. The upcoming quarterly report is expected on the 29th of November 2021. While many of us are getting excited about consumer defensive space, we are going to digest the feasibility of purchasing Arco Platform. We will analyze why it could be a much better year for Arco Platform shareholders.
IMNM
  a day ago at Macroaxis 
By Vlad Skutelnik
While many traders are getting carried away by overanalyzing healthcare space, it is reasonable to summarize Immunome. We will cover the possibilities of making Immunome into a steady grower in December. Here I will also summarize some basic indicators that Immunome investors should consider in December.
CODX
  a day ago at Macroaxis 
By Vlad Skutelnik
Today's article will break down Co Diagnostics. We will analyze why Co Diagnostics investors may still consider a stake in the business. Co-Diagnostics is currently traded for 9.56. The entity has historical hype elasticity of -0.03. The average price elasticity to hype of competition is about -0.08. The firm is forecasted to decline in value after the next headline, with the price expected to drop to 9.53. The average volatility of media hype impact on the company stock price is huge, making predictions on the news or social media along less reliable. The price decrease on the next news is expected to be -0.31%, whereas the daily expected return is currently at -0.15 percent. The volatility of related hype on Co Diagnostics is about 564.37% with expected price after next announcement by competition of 9.48 Given the investment horizon of 90 days the next forecasted press release will be in about 7 days.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas